Skip to main content

InteRNA Joins RNA Silencing Research Consortium

NEW YORK (GenomeWeb News) – Dutch firm InteRNA Technologies today said that it has joined the SIROCCO research consortium, a group of 25 labs and companies from 10 countries studying the use of RNA silencing for therapeutic applications, such as treating cancer.
 
SIROCCO stands for “Silencing RNAs: organizers and coordinators of complexity in eukaryotic organisms.”
 
InteRNA said that it will focus its efforts as part of the consortium on discovery, data mining, and development of diagnostic miRNA and other small RNA profiles through next-generation sequencing in combination with its own small RNA bioinformatics products.
 
The firm will participate in the remaining two and a half years of the project, which was funded with €11.8 million ($15 million) under the EU Sixth Framework Programme.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.